{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:56:40Z","timestamp":1781326600598,"version":"3.54.1"},"reference-count":24,"publisher":"The Fukushima Society of Medical Science","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.5387\/fms.26-00007","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:10:22Z","timestamp":1780956622000},"source":"Crossref","is-referenced-by-count":0,"title":["Changes in characteristics and body mass index-SD after guanfacine extended-release administration for ADHD children"],"prefix":"10.5387","author":[{"given":"Yukihiko","family":"Kawasaki","sequence":"first","affiliation":[{"name":"Fukushima Rehabilitation Center for Children"},{"name":"Fukushima Medical University, Regional Medical Support Center"},{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Fukushima Rehabilitation Center for Children"},{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyohei","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Fukushima Rehabilitation Center for Children"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Fukushima Rehabilitation Center for Children"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Hoshina","sequence":"additional","affiliation":[{"name":"Fukushima Rehabilitation Center for Children"},{"name":"Ohara General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Fukushima Rehabilitation Center for Children"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako Kato and Hayato","family":"Go","sequence":"additional","affiliation":[{"name":"Fukushima Rehabilitation Center for Children"},{"name":"Department of Pediatrics, Fukushima Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3342","reference":[{"key":"1","unstructured":"1. Saito K, Iida J.\u2003Research Group on Diagnosis and Treatment Guidelines for Attention Deficit Hyperactivity Disorder Attention Deficit Hyperactivity Disorder (ADHD) Diagnosis and Treatment Guidelines, 5th Edition (in Japanese) Tokyo Jiho Co., Ltd. 2022."},{"key":"2","unstructured":"2. Hervas A, Huss M, Johnson M, <i>et al.\u2003<\/i>GXR was effective and well tolerated in children and adolescents with ADHD.\u2003Eur Neuropsychopharmacol, <b>24<\/b>:1861-1872, 2014."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Politte LC, Scahill L, Figueroa J, McCracken JT, King B, McDougle CJ.\u2003A randomized, placebocontrolled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms:an analysis of secondary outcome measures.\u2003Neuropsychopharmacology, <b>43<\/b>:1772-1778, 2018.","DOI":"10.1038\/s41386-018-0039-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Sikirica V, Findling R, Signorovitch J, <i>et al.\u2003<\/i>Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attentiondeficit\/ hyperactivity disorder in children and adolescents:applying matching-adjusted indirect comparison methodology.\u2003CNS Drugs, <b>27<\/b>:943-953, 2013.","DOI":"10.1007\/s40263-013-0102-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kawasaki Y, Suzuki Y, Miyazaki K, Suzuki N, Hoshina M, Kato A, et al.\u2003A retrospective single-center study on the characteristics of children with attention-deficit hyperactivity disorder requiring early drug therapy from 2013 to 2022 and changes in treatment over time.\u2003Fukushima J Med Sci, <b>72<\/b>:31-40, 2026.","DOI":"10.5387\/fms.25-00016"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fliers<sup> <\/sup>EA, Buitelaar JK, Maras A, Bul K, H\u00f6hle E, Faraone SV, et al.\u2003ADHD is a risk factor for overweight and obesity in children.\u2003J Dev Behav Pediatr, <b>34<\/b>:566-574, 2013.","DOI":"10.1097\/DBP.0b013e3182a50a67"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kawasaki Y, Suzuki Y, Miyazaki K, Suzuki N, Hoshina M, Kato A, et al.\u2003Characteristics of ADHD subtypes in Japanese children and the association with obesity based on BMI-SD score.\u2003Brain Dev, <b>47<\/b>(6):104475.\u2003doi:10.1016\/j.braindev, 2025.","DOI":"10.1016\/j.braindev.2025.104475"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chao AM, Wadden TA, Berkowitz RI.\u2003Obesity in adolescents with psychiatric disorders.\u2003Curr Psychiatry Rep, <b>21<\/b>:3, 2019.","DOI":"10.1007\/s11920-019-0990-7"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Gurka MJ, Siddiqi SU, Filipp SL, Mercado R, Thompson LA, Janicke DM, Shenkman EA.\u2003Attention deficit hyperactivity disorder medications and BMI trajectories:The role of medication type, sex and age.\u2003Pediatr Obes, <b>16<\/b>:e12738.\u2003doi:10.1111\/ijpo.12738, 2016.","DOI":"10.1111\/ijpo.12738"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hasnain M, Vieweg WV.\u2003Weight considerations in psychotropic drug prescribing and switching.\u2003Postgrad Med, <b>125<\/b>:117-129, 2013.","DOI":"10.3810\/pgm.2013.09.2706"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Reekie J, Hosking SP, Prakash C, Kao KT, Juonala M, Sabin MA.\u2003The effect of antidepressants and antipsychotics on weight gain in children and adolescents.\u2003Obes Rev, <b>16<\/b>:566-580, 2015.","DOI":"10.1111\/obr.12284"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Siddiqi SU, Giordano BP, Dedlow ER.\u2003Excessive Weight Gain With Guanfacine:16.1 Kilograms in 12 Months.\u2003Clin Pediatr (Phila), <b>54<\/b>:793-795, 2015.","DOI":"10.1177\/0009922814548840"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. American Psychiatric Association:<i>Diagnostic and Statistical Manual of Mental Disorders<\/i>, 5th edition, text revision.\u2003Washington DC:American Psychiatric Association, 59-66, 2022.","DOI":"10.1176\/appi.books.9780890425787"},{"key":"14","unstructured":"14. American Psychiatric Association (editing), Takahashi S, Ono Y, Someya T (translation).\u2003Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR).\u2003(in Japanese) Tokyo:Igaku-Shoin;2002."},{"key":"15","unstructured":"15. American Psychiatric Association, The Japanese Society of Psychiatry and Neurology (editing), Takahashi S, Ono Y, Someya T, Kanba S, Ozaki N, Mimura M, et al (translation).\u2003Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). (in Japanese) Tokyo:Igaku-Shoin;2014."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Inokuchi M, Hasegawa T, Anzo M, Matsuo N.\u2003Standardized centile curves of body mass index for Japanese children and adolescents based on the 1978-1981 national survey data.\u2003Ann Hum Biol, <b>33<\/b>:444-453, 2006.","DOI":"10.1080\/03014460600802353"},{"key":"17","unstructured":"17. The Japanese Society of Pediatric Endocrinology.\u2003Software for BMI and BMI percentile SDS.   https:\/\/jspe.umin.jp\/medical\/chart_dl.html.\u2003(in Japanese)"},{"key":"18","unstructured":"18. Ayres LP.\u2003The Binet-Simon Measuring Scale for Intelligence:Some Criticisms and Suggestions.\u2003Psychol Clin, <b>5<\/b>:187-196, 1911."},{"key":"19","unstructured":"19. Sugihara K, Sugihara T, Nakamura J, Okawa I, Nohara R, Ashizawa, N.\u2003Tanaka-Binet Intelligence Test V.\u2003(in Japanese) Tokyo, Denken Publishing, 2003."},{"key":"20","unstructured":"20. Japanese WISC-IV Publication Committee (translation and editing):Japanese WISC-IV Intelligence Test Theory and Interpretation Manual.\u2003(in Japanese) Nippon Bunka Kagakusha, Tokyo, 2010."},{"key":"21","unstructured":"21. Ueno K, Nagoshi S.\u2003S-M Social Life Ability Test 3rd Edition Manual.\u2003(in Japanese) Nihon Bunka Kagakusha, Tokyo, 2016."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Huss M, Dirks B, Gu J, Robertson B, Newcorn JH, Ramos-Quiroga JA.\u2003Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD.\u2003Eur Child Adolesc Psychiatry, <b>27<\/b>:1283-1294, 2018.","DOI":"10.1007\/s00787-018-1113-4"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yu S, Shen S, Tao M.\u2003Guanfacine for the Treatment of Attention-Deficit Hyperactivity Disorder:An Updated Systematic Review and Meta-Analysis.\u2003J Child Adolesc Psychopharmacol, <b>33<\/b>:40-50, 2023.","DOI":"10.1089\/cap.2022.0038"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Margari L, Marzulli L, Gabellone A, de Giambattista C.\u2003Eating and Mealtime Behaviors in Patients with Autism Spectrum Disorder:Current Perspectives.\u2003Neuropsychiatr Dis Treat, <b>16<\/b>:2083-2102, 2020.","DOI":"10.2147\/NDT.S224779"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/advpub\/0\/advpub_26-00007\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:17:51Z","timestamp":1781324271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/advpub\/0\/advpub_26-00007\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":24,"URL":"https:\/\/doi.org\/10.5387\/fms.26-00007","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"value":"0016-2590","type":"print"},{"value":"2185-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"26-00007"}}